1. Prevention CfDCa. 2020.
2. Eder, K., Baffy, N., Falus, A., Fulop, A.K., 2009. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 58(11), 727–736. Epub 2009/06/23. doi: 10.1007/s00011-009-0060-4. PubMed PMID: 19543691.
3. Grasselli, G., Zangrillo, A., Zanella, A., et al., 2020. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Jama. 2020;323(16):1574-8Epub 2020/04/07. doi: 10.1001/jama.2020.5394. PubMed PMID: 32250385; PubMed Central PMCID: PMCPMC7136855 Lifesciences, from Directed Systems, and from Cheetah Medical outside the submitted work. Dr Grasselli reported personal fees and nonfinancial support from Getinge and from Biotest, personal fees from Thermofisher, grants and personal fees from Fisher&Paykel, and personal fees from Draeger Medical outside the submitted work. Dr Iotti reported personal fees from Hamilton Medical, from Getinge Italia, from Eurosets, from Intersurgical, and from Burke & Burke outside the submitted work. Dr Pesenti reported personal fees from Maquet, from Novalung/Xenios, from Baxter, and from Boehringer Ingelheim outside the submitted work. No other disclosures were reported.
4. Hamer, M., Gale, C.R., Kivimäki, M., Batty, G.D., 2020. Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A. 2020. Epub 2020/08/14. doi: 10.1073/pnas.2011086117. PubMed PMID: 32788355.
5. Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study;Hernández-Garduño;Obes. Res. Clin. Pract.,2020